12.02.2014 • NewsaromaticsElevance Renewable SciencesEni

Versalis and Elevance Mull Renewable Ethylene at Porto Marghera

Versalis, petrochemicals subsidiary of Italian energy giant Eni, has signed a memorandum of understanding with U.S. biochemical company Elevance Renewable Sciences to assess the feasibility of a vegetable oil-to-ethylene plant at Porto Marghera, Italy, until recently a production site for PVC.

The methathesis facility, based on Elevance's technology and leveraging Versalis' catalysis knowhow, would be Italy's first such unit. Porto Marghera, formerly an important center of PVC production in Italy, has become virtually moribund after the collapse of Vinyls Italia, the erstwhile Eni and later Ineos business. The plans are part of a restructuring scheme announced last year to reduce Versalis' output of base chemicals while increasing the share of specialties and green chemistry. This, CEO Daniele Ferrari said at the time, would inevitably lead to closure or conversion of commodity plastics units.

To facilitate the renewal process, the company said it had reached agreement with its trade unions to carry out a €200 million revamp of Porto Marghera operations, which would involve suspending production of olefins and aromatics for six months. This, the Eni subsidiary added, would "help to absorb the current downturn in the market and optimize its material balance." It stressed at the same time that the suspension would be "without any impact on downstream production at its sites in Mantova, Ferrara and Ravenna, Italy.

In an unusual twist for Italy, Versalis said the pact with the unions "demonstrates how a collaborative model of industrial relations is key to managing the project efficiently." It said the agreement "activates solutions outlined within the national collective bargaining agreement for employees of the chemical industry from September 2012."

Whitepaper

Excellence in Pharmaceutical Distribution and The Critical Role of Good Distribution Practice (GDP)
Setting the Standard

Excellence in Pharmaceutical Distribution and The Critical Role of Good Distribution Practice (GDP)

Are you ready to elevate your pharmaceutical operations? Download our exclusive whitepaper and discover how compliance with Good Distribution Practice (GDP) is essential for the safety and integrity of pharmaceuticals.

Innovation Pitch

The Start-up Platform for Chemistry & Life Sciences
Discover Tomorrow’s Innovators

The Start-up Platform for Chemistry & Life Sciences

CHEManager Innovation Pitch supports innovation in the chemistry and life sciences start-up scene. The platform allows founders, young entrepreneurs, and start-ups to present their companies to the industry.

most read

Photo
19.03.2025 • NewsInnovation

Data-Driven Enzyme Immobilization

Inseit, based in Bern, develops biocatalysts for industrial setups using enzyme immobilization and biocomputation. Addressing biotech and sustainability challenges, Inseit was selected for Venture Leaders Biotech and won two Nucleate accelerator prizes.

Photo
08.11.2024 • News

Future Prospects in Green Chemistry

The Discourse on Green Chemistry Interactive Pitch Competition, held on November 5, 2024, at Wiley's Berlin office as part of Berlin Science Week, showcased a range of innovative projects aimed at addressing critical environmental challenges.

Photo
29.10.2024 • News

GSK to Invest $800 Million in US Manufacturing Facility

British pharma company GlaxoSmithKline (GSK) plans to invest up to $800 million to expand drug substance and drug product manufacturing capabilities at the company’s US site in Marietta, Pennsylvania. The investment, which GSK said is its largest ever in US manufacturing, is expected to create more than 200 new jobs.

Photo
24.01.2025 • News

And the Winners are: Cynio, EnaDyne and Green Li-ion

The CHEManager Innovation Pitch, the start-up promotion initiative of CHEManager and CHEManager International, has given more than 100 start-ups from over 15 countries the opportunity to present their innovative ideas, products and technologies to a broad target group since its launch in 2019.